Overview
Location
United States, New York
Employees
11-50
Founded date
2017
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| InterAlpen Partners | interalpenllc.com |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 3, 2021 | Bristol Myers Squibb-backed Clade nabs a meaty $87M series A for cell therapy 2.0 | It still feels as if the use of cell therapy is a fresh innovation, but inertia is the enemy of progress, and next-gen approaches are already here. Sponsored by SomaLogic Reliably predict patient response to cancer immunotherapy with the wo... |
| Apr 30, 2021 | How to attract large investors to your direct investing platform | David Teten Contributor Share on Twitter David Teten is founder of Versatile VC and writes periodically at teten.com and @dteten. More posts by this contributor Should you give an anchor investor a stake in your fund’s management company? H... |
| Clade | “Clade — We Connect the Most Sophisticated Investors” |
Reviews 0
FAQ about Clade
When was Clade founded?
Clade was founded in 2017.
Who has invested in Clade?
Parsers VC lists 2 investors of Clade, among them InterAlpen Partners.
What has the press written about Clade?
Parsers VC has collected 4 articles mentioning Clade, among them “Bristol Myers Squibb-backed Clade nabs a meaty $87M series A for cell therapy 2.0” (Nov 3, 2021) and “How to attract large investors to your direct investing platform” (Apr 30, 2021).
Is Clade still active?
Yes, Clade is active; its latest activity on Parsers VC dates from Apr 26, 2025.